The autophagy inhibitor chloroquine overcomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer (2013) - Comments
pubmed: 23575415  doi: 10.1097/jto.0b013e31828c7210  issn: 1556-1380  issn: 1556-0864 

Yiyu Zou, Yi-He Ling, Juan Sironi, Edward L. Schwartz, Roman Perez-Soler, Bilal Piperdi